Seres Therapeutics, Inc. Accrued Liabilities and Other Liabilities
Seres Therapeutics, Inc. (MCRB) had Accrued Liabilities and Other Liabilities of $14.63 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2018-11-08
- 2018-09-30: Accrued Liabilities and Other Liabilities $14.63M.
- 2018-06-30: Accrued Liabilities and Other Liabilities $13.65M.
- 2018-03-31: Accrued Liabilities and Other Liabilities $11.87M.
- 2017-12-31: Accrued Liabilities and Other Liabilities $12.51M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2018-09-30 | $14.63M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $13.65M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $11.87M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $12.51M 10-Q · filed 2018-11-08 |
| 2017-09-30 | $9.59M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $9.72M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $9.55M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $10.81M 10-K · filed 2018-03-08 |
| 2016-09-30 | $15.62M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $10.87M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $7.06M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $5.52M 10-K · filed 2017-03-16 |
| 2015-09-30 | $2.76M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.75M 10-Q · filed 2015-08-10 |
| 2014-12-31 | $1.74M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |